Series C funding round for Silverback Therapeutics raising $85M in September 2020
Series C funding round for Silverback Therapeutics raising $85M in September 2020
| Investor | Firm Type | Partner |
|---|
EcoR1 CapitalLEAD | Hedge Fund | — |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$201.5M
Top Valuation
-
Silverback Therapeutics raised $85M in a Series C round.
The round was announced on 09/01/20.
The round was led by Scott Platshon.